Chief Technology Officer, Board Member

Oskar has more than 25 years of experience from developing distributed, high-performance, systems for clients such as the Singapore Exchange (SGX), and has founded and built several successful IT companies. He holds an MSc in Engineering Physics and a PhD in Computer Science, both from Uppsala University. His doctoral thesis work focused on formal verification methods, specifically with application to computer network protocols.

Chief Executive Officer, Board Member

Frida has broad experience ranging from academic research and early drug discovery to the medical device and pharmaceutical industry. Frida established and manages Schain Reserach, a consultant research organization specializing in real world evidence. Most recently, she was a Global Director at Janssen, Johnson & Johnson, focusing on evidence generation from a market access and medical affairs perspective. In this role she was also a member of the global real-world evidence leadership team. Frida brings a wealth of experience in medical affairs, real-world evidence, epidemiology and commercial aspects of drug development. Frida holds a MSc in Molecular Biology from Lund University and a PhD in Medicine, Hematology, from Karolinska Institutet, where she focused on molecular aspects of inflammation and lymphoma pathogenesis.

Board Member

Malin Heyman has more than 20 years of experience from her work in financial services at Skandinaviska Enskilda Banken (SEB) and Nasdaq as well as co-founder of a fintech company, Swimbird AB. Her roles have ranged from business development, sales to leadership as head of financial services and products. Malin’s extensive experience from strategic work, process development and digitalisation brings significant value as we continue to develop our capabilities and services in evidence generation and health data sciences.

Chairman of the Board

Lars brings 30 years of experience from the med-tech and pharmaceutical industry, including 13 years as General Manager for Janssen, Johnson & Johnson in the Nordics. Lars has a track record of being an extraordinary leader and his experience covers all strategic and operational aspects of bringing innovative treatments to patients.